Skip to main content

Table 3 Association between CDK1and CCNB1 protein expression and clinical features

From: CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis

  

CDK1

p-value

CCNB1

p-value

Gender

n

≤2

>3

1.000

≤3

>3

0.196

 Male

18

2(11.11)

16(88.89)

 

5(27.78)

13(72.22)

 

 Female

14

2(14.29)

12(85.71)

 

1(7.14)

13(92.86)

 

Age (years)

n

  

1.000

  

a0.018

 ≤5

16

2(87.50)

14(12.50)

 

6(37.50)

10(62.50)

 

 > 5

16

2(87.50)

14(12.50)

 

0(0.00)

16(100.00)

 

Tumor diameter

n

  

0.601

  

0.066

 ≤5 cm

20

2(10.00)

18(90.00)

 

6(30.00)

14(70.00)

 

 > 5 cm

11

2(18.18)

9(81.82)

 

0(0.00)

11(100.00)

 

Ethnicity

n

  

1.000

  

1.000

 Han

11

1(9.09)

10(90.91)

 

2(18.18)

9(81.82)

 

 bOther minorities

20

3(15.00)

17(85.00)

 

4(20.00)

16(80.00)

 

Location

n

  

0.488

  

a0.036

 Head and neck

13

1(7.69)

12(92.31)

 

3(23.08)

10(76.92)

 

 Torso and limbs

8

1(12.50)

7(87.50)

 

0(0.00)

8(100.00)

 

 Urinary

5

1(20.00)

4(80.00)

 

3(60.00)

2(40.00)

 

 Abdominal or retroperitoneal

6

1(16.67)

5(83.34)

 

0(0.00)

6(100.00)

 
  1. P < 0.05 indicates a significant association among the variables
  2. aSignificant difference
  3. bincluding Uygur (n = 18), Kazak (n = 1) and Hui (n = 1)